Cetera Investment Advisers Exact Sciences Corp Transaction History

Cetera Investment Advisers

$41.3 Billion
Q1 2024

A detailed history of Cetera Investment Advisers transactions in Exact Sciences Corp stock. As of the latest transaction made, Cetera Investment Advisers holds 107,667 shares of EXAS stock, worth $5.04 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

107,667

Previous 20,211 432.71%

Holding current value

$5.04 Million

Previous $1.4 Million 432.97%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$56.27 - $73.77 $4.92 Million - $6.45 Million	87,456 Added 432.71%	107,667 $7.44 Million
Q1 2024 May 14, 2024	SELL	$56.27 - $73.77 $1.85 Million - $2.42 Million	-32,824 Reduced 61.89%	20,211 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $445,076 - $570,625	7,536 Added 16.56%	53,035 $3.92 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $80,380 - $120,729	1,219 Added 2.75%	45,499 $3.1 Million
Q2 2023 Aug 09, 2023	BUY	$62.68 - $95.05 $21,624 - $32,792	345 Added 0.79%	44,280 $4.16 Million

Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $173,092 - $259,584	-3,668 Reduced 7.71%	43,935 $2.98 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $658,746 - $1.15 Million	21,705 Added 83.81%	47,603 $2.36 Million
Q3 2022 Nov 10, 2022	SELL	$31.97 - $49.37 $28,005 - $43,248	-876 Reduced 3.27%	25,898 $841,000
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $26,102 - $55,876	-733 Reduced 2.66%	26,774 $1.06 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $99,693 - $142,959	1,732 Added 6.72%	27,507 $1.92 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $296,742 - $412,083	4,093 Added 18.88%	25,775 $2.01 Million
Q3 2021 Nov 16, 2021	BUY	$90.24 - $124.05 $113,702 - $156,303	1,260 Added 6.17%	21,682 $2.07 Million
Q2 2021 Aug 13, 2021	BUY	$93.66 - $139.27 $1.17 Million - $1.73 Million	12,443 Added 155.95%	20,422 $2.54 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $1.17 Million - $1.56 Million	-10,040 Reduced 55.72%	7,979 $1.05 Million
Q4 2020 Feb 17, 2021	BUY	$99.61 - $142.12 $1.79 Million - $2.56 Million	18,019 New	18,019 $2.39 Million

Others Institutions Holding EXAS

# of Institutions

697

Shares Held

160M

Call Options Held

5.81M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.28B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Exact Sciences Corp Transaction History